| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
1 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |
| mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
1 |
| mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
1 |